The outbreak’s genesis was linked to the region’s extensive urbanization, which inadvertently created ideal environments for mosquito breeding. Urban water storage practices, unchecked garbage accumulation, and climate factors contributed to the rapid expansion of the mosquito population. Epidemiological data revealed a sharp increase in the mosquito vector density during the initial months of 2024, corresponding closely with the surge in chikungunya cases. This correlation underscored the critical need for integrated vector management programs in rapidly developing urban spaces, where infrastructural changes can unexpectedly influence disease ecology.

As the first cases were reported in January 2024, local healthcare facilities quickly became overwhelmed by patients presenting with symptoms consistent with chikungunya infection: acute fever, polyarthralgia, myalgia, and rash. Laboratory confirmation confirmed the presence of chikungunya virus in serum samples. Early misdiagnoses as dengue fever further complicated initial response efforts. This diagnostic challenge highlighted the necessity for differential diagnostic capabilities in endemic regions, where spectrums of arboviral diseases often overlap clinically but require different management and public health interventions.

The response mounted by Foshan’s municipal health authorities was multifaceted and aggressive. Early detection teams worked in tandem with entomological surveillance units to map infection hotspots and vector breeding sites. Rapid deployment of insecticide spraying, public education campaigns, and community mobilization were initiated to curb mosquito populations and interrupt transmission cycles. Despite these efforts, the outbreak experienced a protracted course, illustrating the difficulties in containing diseases driven by pervasive and resilient vector species.

A particularly impactful intervention was the establishment of a chikungunya fever epidemiological monitoring system, which facilitated real-time data sharing across healthcare institutions and public health agencies. This system enabled more accurate trend analysis, allowing policymakers to allocate resources efficiently and adjust control measures dynamically. Data from this surveillance system showed the epidemic reached a peak by late March 2024 but persisted with sporadic clusters until June, suggesting a prolonged seasonal influence on viral transmission.

Clinical management of chikungunya patients during the outbreak relied on supportive care, as no specific antiviral treatment exists. Pain management for severe joint symptoms was critical, with nonsteroidal anti-inflammatory drugs (NSAIDs) being the mainstay. Importantly, the healthcare system in Foshan adjusted to this need by training physicians and healthcare providers to recognize and manage post-acute or chronic chikungunya arthritis, a condition affecting a subset of patients and posing long-term disability risks. This adjustment underlined the broader clinical and social burden arboviral diseases can impose on affected populations.

One striking epidemiological insight from this outbreak was the demographic distribution of cases. Data indicated a disproportionately high incidence among middle-aged adults, likely reflecting occupational and behavioral factors that increase mosquito exposure risk. Moreover, household clustering of cases reinforced the role of domestic environments as epicenters of transmission. These findings prompted targeted community interventions, such as household larviciding and education on personal protective measures, emphasizing an integrated “One Health” approach linking human health, vector control, and environmental management.

Genomic sequencing performed on viral isolates from Foshan elucidated the genetic lineage of the chikungunya virus responsible for the outbreak. Phylogenetic analysis linked the strain to a Southeast Asian clade known for enhanced transmissibility in Aedes albopictus mosquitoes. This molecular insight provided critical information for anticipating transmission dynamics and tailoring control strategies based on vector-virus compatibility. It also raised concerns about the potential for regional spread to neighboring urban centers with similar ecological conditions.

Reflecting on the outbreak’s trajectory revealed several critical lessons for future epidemic preparedness. Notably, the importance of early detection and rapid vector control emerged as paramount. Delay in recognizing the chikungunya virus’s presence allowed for unchecked transmission in the initial weeks. In response, health authorities committed to strengthening arboviral surveillance infrastructure, integrating climate and environmental data to enable predictive modeling for outbreak risk, and enhancing community engagement frameworks to bolster public compliance with control measures.

Additionally, the Foshan epidemic demonstrated the necessity for regional collaboration. Given the extensive movement of people and goods across Guangdong Province and adjacent regions, collaborative surveillance and joint response protocols are essential. Sharing epidemiological data and harmonizing vector control activities can prevent the establishment of sustained transmission cycles beyond single urban centers. This regional perspective is vital for emerging urban epidemics driven by vector-borne diseases, which often transcend administrative boundaries.

From a scientific standpoint, the outbreak rekindled interest in vaccine development for chikungunya virus. Although candidate vaccines exist, none have reached widespread licensure. The Foshan experience underscored the potential public health impact such vaccines could have in urban centers facing periodic arbovirus epidemics. Furthermore, it bolstered calls for research into novel vector control technologies, including genetically modified mosquitoes and Wolbachia-based biocontrol agents, which offer promising alternatives to insecticides and could transform urban vector management.

Public communication efforts played a crucial role in mitigating panic and misinformation during the outbreak. Foshan’s health authorities deployed multimedia campaigns targeting diverse demographic groups, emphasizing facts about chikungunya transmission, symptom management, and prevention. Transparent updates on outbreak status fostered trust and encouraged public participation in vector control activities. This strategy illustrates the importance of effective risk communication in epidemic contexts, which can directly influence compliance with health advisories and ultimately shape outbreak outcomes.

In summary, the chikungunya fever epidemic in Foshan City in 2024 served as a vivid example of the challenges posed by urban arboviral diseases in an era of rapid urbanization and global environmental change. The epidemic’s dynamics underscored the interplay between viral genetics, vector ecology, human behavior, and public health system readiness. It highlighted the multidimensional nature of epidemic control, from diagnostic precision to community engagement, surveillance innovation, and international cooperation.

Looking forward, the Foshan outbreak is likely to inform a broad swath of public health policies. Strengthened arbovirus surveillance networks, urban planning that incorporates vector control principles, investment in novel countermeasures, and enhanced clinical training for arboviral diseases are among the envisaged strategic outcomes. Furthermore, this event emphasizes the urgency of preparing megacities in Asia and beyond for the recurrent threat of mosquito-borne viral epidemics amid evolving climate patterns.

Ultimately, Foshan’s experience with chikungunya fever calls for a reimagined, holistic approach to managing vector-borne diseases in urban contexts—one that integrates cutting-edge science, resilient health systems, and empowered communities to interrupt the complex web of transmission and reduce the human toll of these epidemics.

Subject of Research:
The outbreak, response, and epidemiological analysis of a chikungunya fever epidemic in Foshan City, China.

Article Title:
The outbreak, response, and reflections on the chikungunya fever epidemic in Foshan City, China.

Article References:
Nama, N., Ma, Y., Zhou, J. et al. The outbreak, response, and reflections on the chikungunya fever epidemic in Foshan City, China. glob health res policy 10, 59 (2025). https://doi.org/10.1186/s41256-025-00458-2

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s41256-025-00458-2

Diphtheria is an acute infectious disease caused by Corynebacterium diphtheriae, a Gram-positive bacterium capable of producing a potent exotoxin that damages respiratory tissues and other organs. Historically, widespread vaccination campaigns had relegated diphtheria to a rarity in Western Europe, rendering it a controlled and manageable disease. However, the sudden increase in cases reported in recent years among marginalized populations warns against complacency. In 2022 alone, the European Centre for Disease Prevention and Control (ECDC) cataloged 362 confirmed cases, predominantly affecting young males recently arrived from conflict regions such as Afghanistan and Syria. The epidemic’s survival beyond emergency intervention reflects both the challenges of controlling infectious diseases in mobile populations and the necessity for robust, cross-border health strategies.

Molecular epidemiology has been central to deciphering the dynamics of this outbreak. Researchers at the Institut Pasteur, collaborating with Santé publique France and other European public health bodies, conducted whole-genome sequencing on 363 bacterial isolates collected from affected individuals. The striking genomic similarity among isolates from disparate countries revealed that transmission likely occurred after migrants had left their original homelands. This genetic homogeneity indicates a common point or series of points where infection was contracted, probably along migratory corridors or within asylum facilities. The genomic data also linked the 2022 epidemic strain with a diphtheria outbreak detected in Germany in 2025, suggesting a silent, ongoing circulation of the bacterium within Western Europe that had gone unnoticed until recently.

Epidemiologically, the epidemic exhibits notable demographic characteristics. A vast majority of infections occurred in males, with a median age of 18, emphasizing a young, predominantly male migrant profile. Clinically, the infections were overwhelmingly cutaneous, accounting for approximately 77% of cases, while respiratory diphtheria—a more severe manifestation—was observed in 15%. Cutaneous diphtheria often presents as skin lesions that can serve as bacterial reservoirs, complicating outbreak containment due to subtler symptoms and reduced clinical suspicion. This clinical pattern complicates diagnosis and underlines the necessity for healthcare providers to maintain heightened vigilance, especially when treating vulnerable individuals and migrant populations with limited healthcare access.

Understanding the origin and pathways of transmission remains a critical hurdle. Although the countries of origin were initially suspected as epidemic reservoirs, the absence of genetic diversity in bacterial strains says otherwise. Instead, the study posits that contamination events occurred during transit or within European host countries’ reception centers. These findings raise pressing questions about the sanitary conditions, healthcare infrastructure, and screening measures along migratory routes. Moreover, the mobility and often informal living conditions of migrants hinder comprehensive epidemiological surveillance, rendering the true scope of the epidemic difficult to gauge and control. This uncertainty calls for innovative approaches in field epidemiology and public health outreach.

Public health officials are responding with renewed urgency. The study asserts that effective vaccination programs within the general population have substantially limited larger spread, but stresses persistent vulnerabilities in specific demographic groups. Maintaining high vaccination coverage remains paramount, alongside increased screening efforts targeted at at-risk populations—particularly migrants, homeless people, injecting drug users, and unvaccinated elderly individuals with comorbidities. The international collaboration facilitating rapid data sharing and coordinated responses is cited as a critical factor in adapting prevention and treatment protocols in real time. This model of open cross-border communication exemplifies modern epidemiological practice in addressing infectious threats.

Clinicians’ awareness is emphasized as a frontline defense against this persistent health challenge. Symptoms of diphtheria, especially the cutaneous form, may be subtle and easily overlooked outside endemic contexts. Consequently, heightened suspicion is warranted when treating vulnerable groups closely linked to migrant communities, including healthcare workers and social service providers. Prompt identification, testing, and administration of appropriate antibiotic therapy, combined with diphtheria antitoxin when indicated, are crucial. The awareness of professional risks among individuals with sustained contact to these communities adds another layer of prevention to curtail potential nosocomial or community transmission.

From a research perspective, the outbreak highlights the enduring need to scrutinize bacterial genomic evolution and antimicrobial resistance. Although current treatment regimens remain effective, the specter of emerging antibiotic resistance necessitates continual surveillance of Corynebacterium diphtheriae strains circulating in these populations. Monitoring genetic changes informs both clinical decision-making and public health policies, guiding vaccination strategies and antibiotic stewardship. The Institut Pasteur and associated reference laboratories underscore the value of integrating molecular biology techniques in epidemiological frameworks.

International cooperation, as demonstrated by this study, represents a crucial pillar for successful outbreak management. The National Reference Center (CNR) for diphtheria, newly appointed as part of the European Reference Laboratory network, plays a pivotal role in unifying diagnostic standards and data aggregation across Europe. This harmonization strengthens the continent’s capacity to promptly detect and respond to diphtheria cases, reducing the window for uncontrolled propagation. Partnerships between research entities, healthcare institutions, and public health authorities exemplify the holistic approach necessary to manage infectious diseases in an era marked by unprecedented human mobility.

In conclusion, this unprecedented diphtheria outbreak among migrant populations in Western Europe serves as a potent reminder of the vulnerabilities that remain despite decades of successful infection control. It exemplifies how socio-political factors, such as mass migration and social marginalization, interact with microbial evolution to shape emerging public health crises. The study’s findings compel sustained vigilance, investment in targeted vaccination, improved surveillance among vulnerable groups, and enhanced clinical awareness. By integrating state-of-the-art genomics with pragmatic public health interventions, European institutions demonstrate a model of resilience and adaptability in combating infectious diseases in complex modern contexts.

Subject of Research: People
Article Title: Corynebacterium diphtheriae outbreak among migrant populations in Europe
News Publication Date: 4-Jun-2025
Image Credits: Institut Pasteur
Keywords: Microbial genetics, Bacterial pathogens